Cone Stephen Mark 4

What Happened
Stephen Mark Cone, a director of biote Corp. (BTMD), was granted two deferred settlement restricted stock unit (RSU) awards on 2026-05-12 totaling 161,481 RSUs (31,481 and 130,000). Each RSU is the economic equivalent of one share of Class A common stock and the grants show a $0.00 per-share acquisition price (derivative awards, not open-market purchases).

Key Details

• Transaction date: 2026-05-12; filing date (Form 4): 2026-05-13 (appears timely).
• Awards: 31,481 RSUs and 130,000 RSUs; total = 161,481 RSUs. Reported acquisition price: $0.00 (derivative award).
• Shares owned after transaction: not specified in the provided excerpt.
• Footnote F1: Each Deferred Settlement RSU equals one share of Class A common stock.
• Footnote F2: The RSUs are fully vested upon grant, but settlement (delivery of shares) is deferred until the reporting person's separation from service.
• Footnote F3: The filing also references an option award that will vest on the earlier of May 12, 2027 or the day before the issuer's 2027 annual meeting, subject to continuous service.
• No sale or purchase of underlying shares was reported—this is a compensation grant to a director, not an open-market trade.

Context
RSU grants to directors are a common form of compensation. Although these RSUs are fully vested, the award specifies deferred settlement—meaning Cone does not immediately receive tradable shares; settlement will occur upon separation from service. Such awards are informational about director compensation but do not necessarily signal the director buying or selling stock.